2021
DOI: 10.4274/tjod.galenos.2021.07277
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA let-7: A promising non-invasive biomarker for diagnosing and treating external genital endometriosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…Grechukhina et al discovered inherited polymorphism of a let-7 miRNA binding site in KRAS in patients with severe endometriosis [ 118 ]. The role of let-7 miRNA is currently under intensive research as a potential biomarker and therapeutic target in endometriosis and gynecological cancers as well [ 119 , 120 ].…”
Section: The Role Of Micrornamentioning
confidence: 99%
“…Grechukhina et al discovered inherited polymorphism of a let-7 miRNA binding site in KRAS in patients with severe endometriosis [ 118 ]. The role of let-7 miRNA is currently under intensive research as a potential biomarker and therapeutic target in endometriosis and gynecological cancers as well [ 119 , 120 ].…”
Section: The Role Of Micrornamentioning
confidence: 99%
“…Pokrovenko et al enrolled 64 endometriotic infertile patients with dysmenorrhea in stages I–IV of disease, and miRNA extraction revealed downregulation of miR-let-7 [ 94 ], although the relative expression in the Log2(ratio) between the patients and controls corresponded to 0.6 [ 94 ]. Regarding dysmenorrhea, in the Bendifallah et al study, 100% of the patients with stages I–IV of endometriosis were dysmenorrheic [ 99 ].…”
Section: Resultsmentioning
confidence: 99%
“…In comparison to CA-125, let-7 exhibited be er specificity for distinguishing patients with and without endometriosis. Let-7 emerged as a promising diagnostic marker, prompting the researchers to plan an endometriosis diagnostic and treatment algorithm [78].…”
Section: Management (Treatment and Prognosis)mentioning
confidence: 99%